Estrogen and Progesterone Market

Progesterone and estrogen are the two most important hormones in the female body. These are steroid hormones that are responsible for various female characteristics in the body.

Estrogen and Progesterone Market contains market size and forecasts of Estrogen and Progesterone in global, including the following market information:

• Global Estrogen and Progesterone Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Estrogen and Progesterone Market Sales, 2017-2022, 2023-2028, (K Pcs)
• Global top five Estrogen and Progesterone companies in 2021 (%)

The global Estrogen and Progesterone market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Estrogen Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Estrogen and Progesterone include Gedeon Richter, Bayer, N.V.Organon, Pfizer Healthcare, Jenapharm, Besins Healthcare, MERCK SERONO, Abbott and Teva Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Estrogen and Progesterone manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Estrogen and Progesterone Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Estrogen and Progesterone Market Segment Percentages, by Type, 2021 (%)

• Estrogen
• Progesterone

Global Estrogen and Progesterone Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Estrogen and Progesterone Market Segment Percentages, by Application, 2021 (%)

• Pharmacy
• Hospital
• Department of Endocrinology

Global Estrogen and Progesterone Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Estrogen and Progesterone Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Estrogen and Progesterone revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Estrogen and Progesterone revenues share in global market, 2021 (%)
• Key companies Estrogen and Progesterone sales in global market, 2017-2022 (Estimated), (K Pcs)
• Key companies Estrogen and Progesterone sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Gedeon Richter
• Bayer
• N.V.Organon
• Pfizer Healthcare
• Jenapharm
• Besins Healthcare
• MERCK SERONO
• Abbott
• Teva Pharma
• Aspen Pharmacare
• Dr.Kade Pharmazeutische Fabrik
• F.I.S.-FABBRICA
• Eli Lilly
• Orion
• AstraZeneca
• Novartis Pharma
• Novo Nordisk